Clinical Trial Update: Real-world Study of Sunvozertinib Treatment in Advanced EGFR-Mutant NSCLC After EGFR-TKI Treatment Failure

View source ↗

Summary

A real-world study is planned to evaluate sunvozertinib in patients with advanced EGFR-mutant non-small cell lung cancer after failure of prior EGFR-TKI therapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Sunvozertinib (Sunvozertinib)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Non Small Cell Lung Cancer | Status: NOT_YET_RECRUITING